Canadian firms to release GMP-compliant MDMA capsules for clinical trials worldwide

United States News News

Canadian firms to release GMP-compliant MDMA capsules for clinical trials worldwide
United States Latest News,United States Headlines
  • 📰 IntEngineering
  • ⏱ Reading Time:
  • 51 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 63%

The psychedelics industry is at the cusp of something big.

of their GMP-compliant MDMA capsules for purposes of clinical trials and for use in authorized patients across the globe. MDMA is the acronym for 3,4-methylenedioxy-methamphetamine, a synthetic drug that became popular by its street name, Ecstasy.

Until a few years ago, Ecstasy, also known by other names such as molly or mandy, was primarily used for. However, the lack of new drug interventions in the field of psychiatry and the side effects of existing drugs have meant that psychedelics are being considered a potential treatment option. To facilitate the quickened research in this direction, the U.S. Food and Drug Administration has awarded MDMA and psilocybin – a compound naturally produced by fungi, 'breakthrough' status.Since MDMA has been abused as a recreational drug, it is placed under the "most restrictive category" of drugs by Drug Enforcement Administration.

While MDMA has previously been synthesized in a non-controlled environment, GMP-compliant MDMA ensures that the same drug is made under conditions supervised by technical experts in an environment that is suitable for the manufacturing of drugs. The drug is extensively tested for its nature and purity before being released to patients or for trials.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

IntEngineering /  🏆 287. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

MDMA expected to be approved to treat PTSD by October: studyMDMA expected to be approved to treat PTSD by October: studyThe Food and Drug Administration will be asked to approve MDMA to treat post-traumatic stress disorder (PTSD) by October — opening the door to use of hallucinogenic drugs to treat mental illn…
Read more »

US could soon approve MDMA therapy — opening an era of psychedelic medicineUS could soon approve MDMA therapy — opening an era of psychedelic medicinePerceptions have shifted dramatically in the past few years on the therapeutic value of illicit drugs such as ecstasy. But questions still linger about what FDA approval might look like.
Read more »

FDA approves first ‘smart crib’ for babiesFDA approves first ‘smart crib’ for babiesThe Food and Drug Administration has approved the first “smart bassinet” whose manufacturer says it reduces safety risks for infants through automated rocking that keeps them flat on their backs.
Read more »

Supreme Court maintains FDA approval of abortion pill, preserving access for nowSupreme Court maintains FDA approval of abortion pill, preserving access for nowJustice Samuel Alito issued a temporary order preserving access to the abortion pill mifepristone that was set to expire at midnight Friday.
Read more »

Supreme Court maintains FDA approval of abortion pill for nowSupreme Court maintains FDA approval of abortion pill for nowThe Supreme Court decided Friday to keep an abortion drug available. The decision is being seen as a win for abortion rights groups, but the battle is still far from over. CBS2's Dick Brennan has more on what this means for abortion rights going forward.
Read more »

FDA Still Struggles to Inspect Foreign Drug Manufacturers After COVID DelaysFDA Still Struggles to Inspect Foreign Drug Manufacturers After COVID DelaysA series of deaths linked to bacteria-tainted eyedrops produced overseas has raised alarm over a lag in FDA inspections.
Read more »



Render Time: 2025-03-10 12:56:15